Mammalian ribonucleotide reductase (EC 1.17.4.1) is composed of two nonidentical subunits, proteins Rl and R2, both required for enzyme activity. The structure of the genomic mouse ribonucleotide reductase Ri gene was compiled from a number of overlapping A clones isolated from a Charon 4A mouse sperm genomic library. The Rl-encoding gene covers 26 kb and consists of 19 exons. All exon-intron boundaries were located by dideoxynucleotide sequencing, showing that intron 7 starts with the variant GC instead of GT. About 3.5 kb of DNA from the 5'-flanking region of the Rl-encoding gene were cloned and sequenced, and the transcriptional start site was determined by nuclease Si mapping of RNA. DNase I footprinting assays on the Ri promoter identified two nearly identical 23-bp-long protein-binding regions. Three protein complexes binding to one of the 23-mer regions were resolved and partially identified by using gel-retardation mobility-shift assays and UV crosslinking. One complex most likely contained Spl, and another complex showed S-phase-specific binding, suggesting a direct role in the cell-cycle-dependent Ri gene expression.
Ribonucleotide reductase (EC 1.17.4.1) catalyzes the direct reduction of all four ribonucleotides to the corresponding deoxyribonucleotides, a reaction crucial for DNA synthesis (1, 2). Enzyme activity is strongly correlated to DNA synthesis, showing maximal activity in the S phase of the cell cycle.
Mammalian ribonucleotide reductase is composed of two nonidentical homodimeric subunits, proteins Rl and R2, both required for activity. Each 45-kDa polypeptide of the R2 subunit contains a nonheme binuclear iron center that, during its formation, generates a tyrosyl-free radical essential for holoenzyme activity. The functional gene encoding the mouse R2 protein is mapped to chromosome 12 and has been cloned and sequenced (3, 4) . The mammalian Rl subunit consists of two 90-kDa polypeptides containing the binding sites for nucleoside triphosphate allosteric effectors and ribonucleoside diphosphate substrates (5). The mouse Rl gene is mapped to chromosome 7, and full-length mouse Rl cDNA has been cloned and sequenced (6) (7) (8) .
The Rl protein can only be detected in proliferating cells, but the levels are constant and in excess throughout the cell cycle. Holoenzyme activity is regulated by an S-phasespecific de novo synthesis and subsequent breakdown of the R2 protein (9, 10). Both the Rl and R2 mRNA levels are undetectable in Go/Gl cells, rise dramatically and in parallel slightly preceding the entry of cells into the S phase, reach the same levels, and then decline as cells enter the G2 + M phases (11). The constant levels of the Rl protein through the different cell-cycle phases are most simply explained by its very long half-life compared to the R2 protein [Rl > 24 hr (12) ; R2 = 3 hr (9)].
The S-phase-specific expression of R2 mRNA is regulated by an S-phase-specific release from a transcriptional block
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. located in the first intron of the R2 gene (13). The R2 promoter, on the other hand, is immediately activated when quiescent cells are stimulated to proliferate, but due to the block this activation only results in short immature R2 transcripts until cells enter the S phase.
We report here the structure of the Rl gene including the nucleotide sequence of the Rl promoter region and all exon-intron boundaries.t The Rl transcription start site was mapped by S1 nuclease protection assays, and DNA-protein interactions in the Rl promoter region were characterized. TTG CCC ACA CCC AAT ATG GCG GCG CA-3'  3'-CGT AAC GGG TGT GGG TTA TAC CGC CG-5'; oligonucleotide OR1 2 (used for UV-crosslinking), 5'-TTG CCC ACA CCC AAT ATG GCG GCA GGG AAC TCG-3' 3'-T CCC TTG  and oligonucleotide containing the consensus sequence for Spl (15), 5'-AAT CGA TCG GGG CGG GGC GAG C-3' 3'-TTA GCT AGC CCC GCC CCG CTC G-5'.
MATERIALS AND METHODS
Abbreviation: GEMSA, gel electrophoresis mobility-shift assay. *To whom reprint requests should be addressed.
tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. X72306).
Proc. Natl. Acad. Sci. USA 90 (1993) High-molecular-weight genomic DNA purified from the liver of a BALB/c mouse was used as template in the PCR reactions. The reactions were done as described by Scharf (17) with the following modifications. Gelatin was omitted from the reaction mixture, which was heated to 97°C
for 10 min and then cooled to 94°C before adding 2.5 units of Amplitaq (Perkin-Elmer/Cetus). The cycling proffle was 94°C for 1 min, 55°C for 2 min, and 72°C for 2 min during 30 cycles. The PCR product was purified by electrophoresis in a 1% low-melting-temperature agarose gel, digested with Sal I or EcoRI, and cloned into the M13 vector for subsequent sequencing. The synthetic oligonucleotide primers contained Sal I or EcoRI sites in their 5' ends to facilitate the subcloning.
Nuclease S1 Protection Assay. For 5'-end mapping of the Rl gene a 1053-bp Sph I (nt -807) to Nsi I (nt +247) DNA fiagment was ligated into the polylinker of M13 mpl9.
Continuously labeled single-stranded DNA was prepared as described (18) by using [a-32P]dCTP (specific activity, 3000 Ci/mmol; 1 Ci = 37 GBq), the primer 5'-AACCGAATTAC-GAACTCCTTCCCGC-3' (nt +75 to +50), and cleavage with HindIII. The resulting 900-nt-long probe had a specific activity of -1 x 109 cpm/pmol. The labeled probe (80,000 cpm) was mixed with 5 pg of tRNA or 5 pg of poly(A)+ mRNA prepared from either hydroxyurea-resistant, R2-overproducing TA 3 cells or parent-type TA 3 cells. Samples were hybridized at 55°C overnight as described (18) and then digested at 37°C for 60 min with 120 units of nuclease S1.
After phenol/chloroform extraction, the protected fragments were ethanol-precipitated and analyzed on a 6% polyacrylamide-urea gel together with a sequencing ladder of a colinear DNA fiagment.
Crude Nuclear Extracts. Nuclear extracts from logarithmically growing Ehrlich-Lettre ascites cells were prepared as described by Parker and Topol (19) with modifications (20) . The protein concentration in the nuclear extracts was usually between 5 mg and 15 mg/ml.
Nuclear extracts from BALB/3T3 cells in different growth phases were prepared as described by Zerivitz and Akusjarvi (21) .
DNase I Footprinting. The pSBl plasmid was end-labeled at the EcoRI/HindIll site by filling-in with the Klenow fragment of DNA polymerase I and [a-32P]dATP (22) . The labeled DNA probe representing the Rl promoter was isolated after recleaving with HindIII/EcoRI, separation on polyacrylamide gels, and electroelution. Incubation of crude nuclear extracts and the DNA probe, DNase I digestion, and separation on 6% polyacrylamide/8 M urea gels were done as described by Ohlsson and Edlund (20) .
GEMSA. Oligonucleotides used for GEMSA were synthesized on an Applied Biosystems model 392 RNA/DNA synthesizer and have been described. Single-stranded oligonucleotides were end-labeled using polynucleotide kinase and [t-32P]ATP (22) . Complementary, end-labeled, singlestranded oligonucleotides were hybridized by mixing them in stoichiometric amounts followed by incubation at 65°C for 15 min and subsequent incubation at 370C, 24°C, and 4°C for 15 min at each temperature. Unincorporated [y-32P]ATP was removed by chromatography on Sephadex GSO columns. The specific activity of the probes was usually =3 x 108 cpm/pg of oligonucleotide.
Binding assays were done essentially as described by Carthew et al. (23) . In all reactions, poly(dI-dC) (66.7 ,g/ml, final concentration) was used as nonspecific DNA. For competition experiments, nuclear extracts were incubated with unlabeled oligonucleotides in the binding buffer at 30°C for 5 min before addition of the labeled probes.
UV CrossHnking of DNA-Protein Complexes. Two different methods for UV crosslinking of DNA-protein complexes were used. In situ crosslinking in gels was done essentially as described (24). Briefly, a 33-mer oligonucleotide 5'-TTG CCC ACA CCC AAT ATG GCG GCA GGG AAC TCG-3' was hybridized to a 10-mer primer 5'-CGA GTT CCC T-3' and filled-in using the Klenow fragment of DNA polymerase I in the presence of bromodeoxyuridine triphosphate (BrdUTP) and [a32-P]dCTP to a specific activity of =1 x 107 cpm per pug. The radioactive probe was incubated with nuclear extract, and DNA-protein complexes were resolved by electrophoresis, as described for GEMSA. The polyacrylamide gel was placed on ice, irradiated for 30 min at a distance of 10 cm with UV320 (Fotodyne model 3-3102), and autoradiographed at +4°C overnight. Slices of gels containing retarded complexes were excised and placed on top of a SDS/10%6 polyacrylamide gel together with protein markers. After electrophoresis the gels were stained with Coomassie brilliant blue, dried in vacuo, and autoradiographed.
The size of proteins binding to the 33-mer oligonucleotide was also determined by UV irradiation directly on the incubation mixture by using UV320 and subsequent separation on SDS/polyacrylamide gels, exactly as described by Chodosh et al. (25) .
RESULTS
Structure of Mouse Rl-Encoding Gene. Somatic-cell-hybrid studies showed that only one Rl protein-related sequence exists in the mouse genome, and it is located on chromosome 7 (6). The structure of the Rl protein-encoding gene was compiled from a number of overlapping A clones isolated from a Charon 4A mouse sperm genomic library using mouse Rl cDNA restriction fragments as a probe (Fig. 1) . One missing overlap and one short region containing multiple EcoRI sites were analyzed by PCR using oligonucleotide primers flanking the missing DNA fragments (Fig. 1) . All exon-intron boundaries, as well as 3.5 kb of the promoter region and 0.3 kb of the 3' end, were sequenced after subcloning of suitable restriction endonuclease fragments into bacteriophage M13.
A schematic structure of the Ri protein-encoding gene is shown in Fig. 1 ; the transcribed sequence covers 26 kb, and there are 19 exons. All introns follow the general rule and start with the sequence GT and end with AG, except for intron number 7, which starts with GC (Table 1 ). All exon sequences agree with the published Rl cDNA sequence, except for a thymine instead of the earlier reported cytosine in nt 1727, a change that does not affect amino acid sequence. The translational start codon ATG at position 243 is located in the 3' end of the first exon, and the stop codon TGA at position 2619 is located in the last exon. The overall structure of the Rl gene was confirmed by probing Southern blots of EcoRI-digested high-molecular-weight mouse genomic DNA with Rl cDNA fragments hybridizing to the different genomic EcoRI fragments. Fig. 2 shows the nucleotide sequence of the 5' flanking DNA. To map the transcription start site, we performed an Si nuclease protection assay using poly(A)+ RNA preparations from both parent-type and hydroxyurea-resistant, R2-overproducing mouse TA 3 cells and a continuously labeled 900-nt-long single-stranded DNA probe. Several protected fragments were identified corresponding to transcription starts at the thymidine nucleoside at position +1, the two thymidine nucleosides at positions +4 and +5, the guanosine nucleoside at position + 7, and the two thymidine nucleosides at positions +10 and + 11 (data not shown). The same pattern was obtained with RNA from both cell types.
No TATA homology was found in the Ri promoter region, but a potential Spl-binding site in reverse orientation is found at position -38 to -33, and two CCAAT sequences are located at positions -133 to -129 and -179 to -175.
Localization of Protein-Binding DNA Elements in the Rl Promoter Region. DNase I footprinting analyses were done to detect and localize binding sites for transcription factors in the mouse Ri promoter region. A 507-bp Rsa I to EcoRI fragment from the mouse Ri promoter containing potential binding sites for known transcription factors (see Fig. 2 ) was used as a probe. Preliminary in vitro nucle'ar run-on experiments and Rl promoter-reporter gene assays suggested a promoterdependent ce'll-cycle regulation of Rl mRNA expression (data not shown). This result contrasted to the S-phasespecific expression of R2 mRNA that is regulated at the transcript-elongation level (13). To explore the possibility that the binding of any A or B proteins to the P footprint was S-phase specific, nuclear extracts were prepared from BALB/3T3 cells at 0 hr, 4 Kr, and 16 hr after serum stimulation of quiescent cells. These extracts were then used in a GEMSA together with the ORi 1 oligonucleotide (Fig. 5) . Neither the A nor the B p'rotein-DNA complexes showed any cell-cycle-specific variation. Instead, another protein-DNA complex, C, appeared, barely seen when using extracts prepared from logarithmically growing cells. The C complex was absent at the 0-hr and 4-hr time points but was easily detected in the nuclear extract prepared from S-phaseenriched cells (16 hr).
To determine the size ofthe retarded proteins, another pair of oligonucleotides (OR1 2) was synthesized (see Materials and Methods) such that one of the oligonucleotides acted as a primer on the other one, thus allowing incorporation of the UV-inducible crosslinker BrdUMP and continuous [a-32P]d-CMP labeling throughout the oligonucleotide. This oligonucleotide was subjected to normal GEMSA with high amounts of labeled oligonucleotide and nuclear extract (Fig. 6a) . Under these conditions, the S-phase-specific C complex could be detected even in an extract from logarithmically growing cells. However, in this extract the C complex appeared weaker relative to the A and B complexes than in the nuclear extract from S-phase-enriched cells (Fig. 5) . The gel was irradiated with UV320, and the three bands were individually excised and subjected to SDS/PAGE. Only one band (B) could be visualized, but it had the size reported for the Spl protein (15 To further identify the B protein, the BrdUMP-labeled oligonucleotide (OR1 2) was incubated with either the crude nuclear extract or recombinant human Spl protein (Promega). The mixtures were irradiated with UV320 as described (25) and subjected to SDS/PAGE. Fig. 6b shows two proteins in the crude extract crosslinked to the oligonucleotide; these proteins had the same mobility as recombinant human Spl protein that was also crosslinked to the OR1 2 oligonucleotide. Furthermore, a GEMSA using the OR1 2 oligonucleotide, a nuclear extract, and a competing unlabeled oligonucleotide containing the consensus sequence for the Spl protein exclusively affected the B complex (data not shown). This, again, supports the conclusion that complexes A and B arise from the binding of different proteins and argues against the hypothesis that complex A arises from additional protein(s) binding to complex B.
From these experiments we conclude that at least three protein complexes bind to the ,B footprint, and one of them (complex B) most likely contains Spl.
DISCUSSION
The 26-kb-long genomic Rl gene has a structure typical for mammalian genes with a number of short exons followed by a longer last exon. The seventh intron in the Ri gene shows a variant 5' splice site starting with GC instead of the invariant GT. This unusual type of 5' splice site has only been seen in a very limited number of higher eukaryotic genes (26). The GC substitution seems the only one allowed for correct cleavage of the 5' sites, but cleavage occurs more slowly compared with normal GT sites. This may be an explanation for the low levels of Rl transcripts in the cell.
As expected, mapping ofthe 5' end ofthe Rl gene indicated multiple transcription start sites, typical for genes controlled by TATA-less promoters. The most 5'-located Rl transcription start correlated exactly to the first nucleotide of the previously reported Rl cDNA clone D 65 isolated from an Okayama-Berg library (8), confirming that the sequence represented a full-length Rl cDNA.
Comparing the 5' upstream promoter sequence of the Rl gene with the corresponding sequence from other cell-cycleregulated genes, such as the human and mouse thymidine kinase genes (27, 28), the hamster histone H-3.2 gene (29), and the mouse R2 gene (4), showed that the Ri promoter contained two CCAAT sequences and one inverted Splbinding site, but there were no other obvious sequence homologies. However, analyses of DNA-protein interactions in the Ri promoter revealed two 23-mer sequences protected from DNase I cleavage when incubated with a crude nuclear protein extract. Interestingly, these two sequences are identical except for 1 bp. The more upstream ( footprint contains one of the potential CCAAT-binding sequences, but this region is not present in the downstream a footprint due to a 1-bp difference between the footprints (C -+ T). Neither the second consensus sequence for CCAATbinding proteins, located between footprints a and (, or the inverted Spl-binding region located downstream from both footprints showed any protection in our DNase I footprinting assays. However, gel-mobility-shift assays and UVcrosslinking experiments, instead, indicated Spl to be one of the proteins binding to footprint 13, even though this region does not contain any perfect Spl-binding sequence.
One of the proteins (C) binding to footprint 8 in the Ri promoter was preferentially detected in nuclear extracts prepared from S-phase-enriched BALB/3T3 cells. This result suggests that the S-phase-specific expression of Ri mRNA (11) is regulated at the promoter level, but a more definite answer has to await further studies. This result would then contrast with the S-phase-specific regulation of R2 mRNA, which is regulated by an S-phase-specific release from a transcriptional block located 87 nt downstream of the first exon-intron junction.
Studies of the promoter region of other genes encoding S-phase-specific proteins have identified several transcription factors binding to their promoters in a cell-cycledependent way. Dalton and Wells (30, 31) have identified a factor (Hi-SF) that interacts with an AC-box sequence 100 bp upstream from the cap site in the chicken histone Hi gene. Binding of Hi-SF to the AC box increases i0-fold as cells pass into S phase, and this binding promotes enhanced transcription ofthe Hi gene both in chicken and human cells. A transacting factor (Yi), interacting with a sequence in the murine thymidine kinase promoter, also shows cell-cycledependent binding after serum stimulation of quiescent cells (32). The sequence of footprint ( in the Ri promoter has no obvious homology to the sequences recognized by the Hi-SF or Yi proteins, and we have not yet identified the Ri promoter S-phase-specific binding protein.
